BioCorRx (BICX) Gross Margin (2011 - 2026)
BioCorRx (BICX) posted Gross Margin of 88.26% for Q1 2026, down 11.74% sequentially from 100.0% in Q1 2025, and down 1174.0% YoY from 8.22% in Q1 2025.
BioCorRx (BICX) Gross Margin (2011 - 2026) Analysis & Trends
BioCorRx has reported Gross Margin for 16 years, with the latest figure at 88.26% in Q1 2026.
- Quarterly Gross Margin fell 1174.0% year-over-year to 88.26% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 24.98% (down 7502.0% YoY) and the FY2024 annual result came in at 78.25%, up 1861.0% from the prior year.
- Gross Margin retreated to 88.26% in Q1 2026 per BICX's latest filing, from 100.0% in the prior quarter.
- Over five years, Gross Margin peaked at 100.0% in Q2 2024 and troughed at 31.08% in Q4 2023.
- A 5-year average of 76.94% and a median of 85.62% in 2026 frame the typical range for Gross Margin.
- The sharpest annual moves came in 2023 and 2024: Gross Margin sank 5846 bps in 2023, then surged 5284 bps in 2024.
- Over 5 years, Gross Margin stood at 89.53% in 2022, then slumped by 65 bps to 31.08% in 2023, then jumped by 222 bps to 100.0% in 2024, then changed by 0 bps to 100.0% in 2025, then decreased by 12 bps to 88.26% in 2026.
- According to Business Quant data, Gross Margin over the past three periods registered 88.26%, 100.0%, and 100.0% for Q1 2026, Q1 2025, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 88.19 Bn | 90.61 Bn | 15.19 Bn | 75.07% |
| 2 | Tenet Healthcare | 21.59 Bn | 21.56 Bn | 4.45 Bn | 79.14% |
| 3 | Encompass Health | 12.19 Bn | 12.86 Bn | 1.34 Bn | 84.04% |
| 4 | Davita | 11.52 Bn | 12.39 Bn | 1.16 Bn | 32.70% |
| 5 | Ensign | 10.59 Bn | 10.27 Bn | 306.24 Mn | 21.26% |
| 6 | Universal Health Services | 8.79 Bn | 8.72 Bn | 3.29 Bn | 70.85% |
| 7 | Pacs | 7.04 Bn | 6.88 Bn | 338.46 Mn | 23.70% |
| 8 | Chemed | 6.96 Bn | 6.92 Bn | 221.47 Mn | 32.90% |
| 9 | Concentra Group Holdings Parent | 4.52 Bn | 4.38 Bn | 192.10 Mn | 31.70% |
| 10 | BioCorRx | 1.49 Mn | 1.47 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 88.26% |
| Mar 31, 2025 | 100.00% |
| Jun 30, 2024 | 100.00% |
| Mar 31, 2024 | 53.95% |
| Dec 31, 2023 | 31.08% |
| Sep 30, 2023 | 61.74% |
| Jun 30, 2023 | 47.16% |
| Mar 31, 2023 | 78.55% |
| Dec 31, 2022 | 89.53% |
| Sep 30, 2022 | 97.52% |
| Jun 30, 2022 | 82.97% |
| Mar 31, 2022 | 92.52% |
| Dec 31, 2021 | 82.14% |
| Sep 30, 2021 | 88.41% |
| Jun 30, 2021 | 88.57% |
| Mar 31, 2021 | 93.76% |
| Dec 31, 2020 | -30.29% |
| Sep 30, 2020 | 44.48% |
| Jun 30, 2020 | 18.36% |
| Mar 31, 2020 | 37.84% |